INCYTE CORPORATION
Patent Owner
Stats
- 72 US PATENTS IN FORCE
- 19 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 72 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 7,869 Total Citation Count
- Feb 17, 1995 Earliest Filing
- 331 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0283,783 HUMAN BETA-ADRENERGIC RECEPTOR KINASE POLYPEPTIDE AND METHODSJun 15, 17Oct 05, 17[C12N, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9918990 Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitorsJun 20, 16Mar 20, 18[A61K, C07D]
9890162 Bicyclic aromatic carboxamide compounds useful as pim kinase inhibitorsJan 13, 17Feb 13, 18[C07D]
9885717 Methods for detecting expression levels of human signal peptide-containing proteins (HSPP)Aug 11, 16Feb 06, 18[A61K, G01N, C07K]
9822124 Bicyclic heteroaromatic carboxamide compounds useful as Pim kinase inhibitorsJul 13, 15Nov 21, 17[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0065,447 SURVIVAL BENEFIT IN PATIENTS WITH SOLID TUMORS WITH ELEVATED C-REACTIVE PROTEIN LEVELSAbandonedAug 19, 14Mar 05, 15[A61K, C07D, G01N]
2014/0227,278 ANTIBODIES TO HUMAN SIGNAL PEPTIDE-CONTAINING PROTEINSAbandonedFeb 11, 14Aug 14, 14[C07K]
2014/0155,377 3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORSAbandonedFeb 06, 14Jun 05, 14[C07D]
8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodiesExpiredAug 10, 10Dec 31, 13[A61K, C07K]
2013/0190,250 Polynucleotides Encoding Human Signal Peptide-Containing ProteinsAbandonedSep 14, 12Jul 25, 13[C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
